Interleukin-6 trans signalling enhances photodynamic therapy by modulating cell cycling.
about
Boosting Tumor-Specific Immunity Using PDTIL-6 potentiates tumor resistance to photodynamic therapy (PDT).Inhibition of NF-κB in Tumor Cells Exacerbates Immune Cell Activation Following Photodynamic Therapy.Tropomyosin Receptor Kinase C Targeted Delivery of a Peptidomimetic Ligand-Photosensitizer Conjugate Induces Antitumor Immune Responses Following Photodynamic TherapyPhotodynamic therapy (PDT) of cancer: from local to systemic treatment.Hypericin-photodynamic therapy leads to interleukin-6 secretion by HepG2 cells and their apoptosis via recruitment of BH3 interacting-domain death agonist and caspases.
P2860
Interleukin-6 trans signalling enhances photodynamic therapy by modulating cell cycling.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Interleukin-6 trans signalling enhances photodynamic therapy by modulating cell cycling.
@ast
Interleukin-6 trans signalling enhances photodynamic therapy by modulating cell cycling.
@en
type
label
Interleukin-6 trans signalling enhances photodynamic therapy by modulating cell cycling.
@ast
Interleukin-6 trans signalling enhances photodynamic therapy by modulating cell cycling.
@en
prefLabel
Interleukin-6 trans signalling enhances photodynamic therapy by modulating cell cycling.
@ast
Interleukin-6 trans signalling enhances photodynamic therapy by modulating cell cycling.
@en
P2093
P2860
P356
P1476
Interleukin-6 trans signalling enhances photodynamic therapy by modulating cell cycling.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6604073
P407
P577
2007-11-06T00:00:00Z